[ad_1] Guardant Health (NASDAQ:GH) stated it has entered into an open market sale agreement with Jefferies with respect to an at-the-market providing program below which the corporate could provide and promote shares of…
Month: August 2024
[ad_1] Ocean Biomedical (NASDAQ:OCEA) acquired a notice from Nasdaq stating that as a result of the corporate has not but filed its quarterly report on Form…
[ad_1] Entero Therapeutics receives Nasdaq notification regarding delayed form 10-Q [ad_2] Source: Seekingalpha
[ad_1] Gilnature/iStock by way of Getty Images Pharmaceutical firm ARCA biopharma (NASDAQ:ABIO) stated on Friday its board has permitted a reverse stock split of its shares…
[ad_1] Trials for psychedelic drug candidate for PTSD under scrutiny by FDA – report [ad_2] Source: Seekingalpha
[ad_1] JP Yim The head of the World Health Organization (WHO) has mentioned that a world response plan to fight the continuing mpox outbreak would require…
[ad_1] Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business centered on producing radioactive chemical compounds…
[ad_1] travellinglight/iStock by way of Getty Images Shortly after a U.Ok. watchdog declined to endorse Biogen’s (NASDAQ:BIIB) Alzheimer’s drug Leqembi to be used within the nation’s…
[ad_1] U.Ozel.Images/E+ by way of Getty Images Although different firms are poised to have GLP-1 receptor agonist medicine for weight loss authorized, they don’t seem to…
[ad_1] ImmunoPrecise Antibodies (NASDAQ:IPA) acquired a written notification from Nasdaq, notifying them that they don’t adjust to the minimal bid worth requirement outlined within the Nasdaq…